McLeod Interventional Cardiologists and Electrophysiologists are now able to treat patients who were once potentially ineligible for interventional cardiac procedures such as the placement of stents and electrophysiology procedures like Ventricular Tachycardia ablation, due to the excessive risk the procedure would place on their heart. A device designed to provide temporary circulatory support and reduce the workload of the heart muscle is being used by the physicians of the McLeod Heart and Vascular Institute. This device, the Impella, is a heart pump that is able to increase cardiac output for patients whose heart would be unable to tolerate the stress of an interventional cardiac procedure.
The Impella is inserted through the femoral artery, an artery in the groin area. Using a standard catheter wire, the pump is guided up to the heart and into the left ventricle. Once in place, the Impella works by pulling the blood from the left ventricle out to the aorta. The aorta transports the blood from the left ventricle and distributes it through the rest of the body.
This short-term device provides extra support to the heart during an interventional cardiac procedure, thereby reducing any potential negative outcomes.
The Impella, the "world's smallest heart pump," is a temporary device that is able to perform part of the heart's work for patients whose hearts have difficulty pumping blood throughout the body.